EXCLUSIVE INVESTMENT BANKING AGREEMENTExclusive Investment Banking Agreement • May 5th, 2020 • New York
THIS AGREEMENT (the “Agreement”) is entered into as of this 12th day of March 2013 (the “Effective Date”) by and between CARDAX PHARMACEUTICALS, INC. (hereafter the “Client”) and AGINCOURT LTD, with its principal address at 10 South Riverside Plaza, #1800, Chicago, IL 60606 USA (the “Banker”).
AMENDMENT NO.1 TO EXCLUSIVE INVESTMENT BANKING AGREEMENTExclusive Investment Banking Agreement • May 31st, 2013 • SANUWAVE Health, Inc. • Surgical & medical instruments & apparatus
This Amendment No. 1 to Exclusive Investment Banking Agreement (this “Amendment”), dated as of May 30, 2013, is entered into by and among SANUWAVE Health, Inc., a Nevada corporation (the “Client”), and CIM Securities, LLC, a Colorado limited liability company (the “Banker”)
EXCLUSIVE INVESTMENT BANKING AGREEMENTExclusive Investment Banking Agreement • August 19th, 2009 • Hawk Systems, Inc. • Services-miscellaneous amusement & recreation • New York
THIS AGREEMENT (the “Agreement”) dated as of June 4, 2008 by and between Hawk Biometric Technologies, Inc. with its principal address at 777 South Flagler Dr. STE. 800, West Palm Beach, FL 33401 (hereafter the “Company”) and Cresta Capital Strategies, LLC, with its principal address at 1175 Walt Whitman Road Ste 100 Melville, NY 11747 USA (the “Banker”).
